BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34082136)

  • 1. De novo molecular design and generative models.
    Meyers J; Fabian B; Brown N
    Drug Discov Today; 2021 Nov; 26(11):2707-2715. PubMed ID: 34082136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative Models for De Novo Drug Design.
    Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
    J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unleashing the power of generative AI in drug discovery.
    Gangwal A; Lavecchia A
    Drug Discov Today; 2024 Jun; 29(6):103992. PubMed ID: 38663579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guided structure-based ligand identification and design via artificial intelligence modeling.
    Di Filippo JI; Cavasotto CN
    Expert Opin Drug Discov; 2022 Jan; 17(1):71-78. PubMed ID: 34544293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 11. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges.
    Thomas M; Boardman A; Garcia-Ortegon M; Yang H; de Graaf C; Bender A
    Methods Mol Biol; 2022; 2390():1-59. PubMed ID: 34731463
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Grisoni F; Schneider G
    Chimia (Aarau); 2019 Dec; 73(12):1006-1011. PubMed ID: 31883552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Generative Models in
    Pang C; Qiao J; Zeng X; Zou Q; Wei L
    J Chem Inf Model; 2024 Apr; 64(7):2174-2194. PubMed ID: 37934070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
    Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.